EU OKs Novartis drug patch for Alzheimer's

09/24/2007 | Forbes

The European Commission has approved Novartis AG's Exelon skin patch for the treatment of Alzheimer's disease, the company said. The patch, which was granted FDA approval last July, administers the drug to treat mild to moderate dementia symptoms.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care